OutsourcedPharma.com, CRO, CMO, Pharmaceutical Drug Development Services

7 CEOs Say Outsourcing Advancing … On Swirling Currents (Part 1)
How’s it going in the global BioPharma outsourcing industry? I reached out to 7 CEOs at global CROs/CDMOs for trends from the trenches – or at least the frontlines.

More From the Editor

Launch Of Turing Pharmaceuticals Announced – New Drug Company To Focus On Treating Unmet Medical Needs Across Broad Therapeutic Areas
Turing Pharmaceuticals AG announced its official launch recently, along with news of three acquisitions for its commercial operations and development pipeline. The company also introduced its senior management team.

More News

Dermal Toxicology: A Multifaceted Approach To Meet Today’s Research Needs
Developing a dermal NCE generally follows the same path as other small molecule NCEs administered orally or systemically, except that the dermal route is used in a non-rodent model.
Electronic Informed Consent: Considerations For Implementation In Clinical Trials
In an era where data acquisition (eg. ePRO), capture (EDC) and storage (eTMF) are done electronically, it is the logical consequence to do the same for the informed consent process as all the advantages of the electronic modality equally apply to this process.
Keep Your Eye On The Apple: Apple Makes A Move On The Watch Market—Could Pharma Be Next?
CEO of Rolex sounds like a pretty desirable job title and it might have been fun a year ago, when Dufour took the job. Back then, rumors of the Apple Watch were just rumors, and the idea of a tiny computer on the back of your wrist seemed a touch ridiculous.
Just How Big Is Big Data?
Despite all of this interest, a great deal of confusion remains around Big Data. Not only are there never-ending debates about what Big Data is, there's a huge range of possible Big Data solutions out there to choose from, only a few of which will be appropriate for any given situation or problem.
A Growing Number Of Pharmas Are Thinking Outside The Box
Everyone knows the mantra – reduce, reuse, recycle – but reusing temperature-sensitive packaging has not been the normal practice in the pharmaceutical/life science sectors. However, changes are afoot.
From Cold To Controlled
World Courier Ground Europe reveals impressive test results for new fleet of temperature-controlled vehicles.

More Insights

Pharma Outsourcing Trends: Industry Leaders, Equity Financing, And Vendor Consolidation
The outsourcing industry continues to gain a bigger share of the dollars spent on preclinical, clinical, and post approval functions. To accurately quantify the size of various segments of the outsourcing market, this report acknowledges that task is next to impossible.
Hiring A Chief Medical Officer May Sound Good, But…
Laurie Halloran has seen many firms succeed where others have failed. She will tell you she started her company after speaking to many executives about how to grow their companies, get funding, make it through clinical testing, and finally going commercial.
WIB Profile: Emerging Markets Drive Growth In Biologics
I was able to catch up with Daniella Kranjac, integration leader and head of commercial operations, to discuss her position with GE Healthcare and the trends she sees occurring in the biologics market.
21st Century Cures Gets Closer To Revolutionizing The Pharma Industry
If you’re a regular reader of my articles, you know my background is in economics, and I tend to favor free markets over more central control. But when I first became aware of the 21^st Century cures initiative last year, I felt it was something the industry needed.
Will The State Of New York Stifle Pharma Innovation?
An anti-trust lawsuit is pending in the U.S. Court of Appeals for the Second Circuit that could have an impact on the ability of a pharmaceutical company to innovate and invest in medicines they think will best serve patient needs.